Article
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
2022-08-23
Abstract excerpt
<h4>Background: </h4> Pancreatic cancer (PC) is highly malignant. Chemotherapy is the main treatment strategy, especially for patients with advanced PC. However, chemoresistance has always been a frequently encountered bottleneck. Hence, there is an urgent need to enhance the sensitivity of PC to gemcitabine (GEM). <h4>Results: </h4>: We demonstrated that SH3BP5-AS1 was significantly upregulated in GEM-resistant P...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- be92d573-8908-51e5-be2a-821eaf09c24a
- DOI
- 10.21203/rs.3.rs-1926149/v1
